These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14744276)

  • 41. Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial).
    Valencia R; Price MJ; Sawhney N; Lee SS; Wong GB; Gollapudi RR; Banares M; Schatz RA; Teirstein PS
    Am J Cardiol; 2007 Oct; 100(7):1099-102. PubMed ID: 17884370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bridging Experience With Eptifibatide After Stent Implantation.
    Barra ME; Fanikos J; Gerhard-Herman MD; Bhatt DL
    Crit Pathw Cardiol; 2016 Sep; 15(3):82-8. PubMed ID: 27465001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina.
    Deibele AJ; Kirtane AJ; Pinto DS; Lucca MJ; Neva C; Shui A; Murphy SA; Tcheng JE; Gibson CM
    J Thromb Thrombolysis; 2006 Aug; 22(1):47-50. PubMed ID: 16786232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
    Biondi-Zoccai G; Valgimigli M; Margheri M; Marzocchi A; Lettieri C; Stabile A; Petronio AS; Binetti G; Bolognese L; Bellone P; Sardella G; Contarini M; Sheiban I; Marra S; Piscione F; Romeo F; Colombo A; Sangiorgi G
    Am Heart J; 2012 May; 163(5):835.e1-7. PubMed ID: 22607870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter study of the feasibility and safety of using the memotherm carotid arterial stent for extracranial carotid artery stenosis.
    Qureshi AI; Suri MF; New G; Wadsworth DC; Dulin J; Hopkins LN
    J Neurosurg; 2002 May; 96(5):830-6. PubMed ID: 12005390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature.
    Pickett AM; Taylor DA; Ackman ML
    Pharmacotherapy; 2010 Apr; 30(4):127e-33e. PubMed ID: 20334463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia.
    Yang EH; Perez E; Zhiroff KA; Burstein S
    Tex Heart Inst J; 2011; 38(2):174-8. PubMed ID: 21494531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose tirofiban administered as bolus-only during percutaneous coronary intervention.
    Marmur JD; Poludasu S; Agarwal A; Manjappa N; Cavusoglu E
    J Invasive Cardiol; 2008 Feb; 20(2):53-8. PubMed ID: 18252967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical outcomes of intracoronary eptifibatide bolus only versus intracoronary bolus and intravenous infusion of eptifibatide in primary percutaneous coronary intervention.
    Soon D; Ho HH; Loh KK; Ooi YW; Foo D; Jafary FH; Ong PJ
    Acute Card Care; 2012 Mar; 14(1):42-4. PubMed ID: 22273457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term mortality after bolus-only administration of abciximab, eptifibatide, or tirofiban during percutaneous coronary intervention.
    Marmur JD; Poludasu S; Lazar J; Cavusoglu E
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):214-21. PubMed ID: 19156882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycoprotein IIb/IIIa antagonists during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
    Zahn R; Ischinger T; Hochadel M; Mark B; Zeymer U; Jung J; Schramm A; Hauptmann KE; Seggewiss H; Janicke I; Mudra H; Senges J;
    Clin Res Cardiol; 2007 Oct; 96(10):730-7. PubMed ID: 17593309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
    Akerblom A; James SK; Koutouzis M; Lagerqvist B; Stenestrand U; Svennblad B; Oldgren J
    J Am Coll Cardiol; 2010 Aug; 56(6):470-5. PubMed ID: 20670756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bilateral carotid angioplasty and stenting.
    Henry M; Gopalakrishnan L; Rajagopal S; Rath PC; Henry I; Hugel M
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):275-82. PubMed ID: 15736256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy.
    Saw J; Densem C; Walsh S; Jokhi P; Starovoytov A; Fox R; Wong G; Buller C; Ricci D; Mancini GB; Fung A
    JACC Cardiovasc Interv; 2008 Dec; 1(6):654-9. PubMed ID: 19463380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of latest-generation self-expanding stents in patients with NASCET-ineligible severe symptomatic extracranial internal carotid artery stenosis.
    Linfante I; Hirsch JA; Selim M; Schlaug G; Caplan LR; Reddy AS
    Arch Neurol; 2004 Jan; 61(1):39-43. PubMed ID: 14732618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate results.
    Schneiderman J; Morag B; Gerniak A; Rimon U; Varon D; Seligsohn U; Shotan A; Adar R
    J Endovasc Ther; 2000 Aug; 7(4):263-72. PubMed ID: 10958289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms.
    Yi HJ; Gupta R; Jovin TG; Tayal A; Genevro J; Gologorsky Y; Horowitz M
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1856-60. PubMed ID: 17032856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention.
    Suleiman M; Gruberg L; Hammerman H; Aronson D; Halabi M; Goldberg A; Grenadier E; Boulus M; Markiewicz W; Beyar R
    J Invasive Cardiol; 2003 Jun; 15(6):319-23. PubMed ID: 12777670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative effectiveness and safety of a catheterization laboratory-only eptifibatide dosing strategy in patients undergoing percutaneous coronary intervention.
    Gurm HS; Hosman C; Bates ER; Share D; Hansen BB;
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001880. PubMed ID: 25657314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention.
    Marmur JD; Poludasu S; Agarwal A; Vladutiu P; Feit A; Lapin R; Cavusoglu E
    J Invasive Cardiol; 2006 Nov; 18(11):521-6. PubMed ID: 17090813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.